The Swedish Rheumatology Research Group conducts research in hopes of alleviating suffering and preventing damage caused by arthritis, osteoporosis and other rheumatic diseases. The department undertakes drug and biologic studies that are often sponsored by major drug manufacturers.
The department's philosophy is to perform high-quality, ethical studies; to maintain the patient’s welfare and quality care; and to make substantial contributions to the treatment of arthritis, osteoporosis and other rheumatic diseases.
View a list of current rheumatology-related search studies being conducted at Swedish.
Studies primarily involve:
Swedish rheumatology research undertakes a wide variety of studies. The department’s focus includes the first trial of a drug as well as testing the optimal effect and safety of drugs alone or in combination.
Philip J. Mease, M.D.
Dr. Mease has been practicing for 20 years in rheumatology and internal medicine. He currently works with Seattle Rheumatology Associates. He is a member of the American College of Rheumatology, the American College of Physicians, the American Society of Bone and Mineral Research, the Northwest Rheumatism Society and the International Society of Clinical Densitometry. His primary research interests include pain and rheumatologic and inflammatory diseases, such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, lupus, osteoporosis and osteoarthritis. Dr. Mease is very involved in physician education and public education about rheumatic diseases and their treatment. He has received the Educator of the Year award from the American College of Rheumatology. He also actively consults with pharmaceutical and biotechnology companies in high-quality and ethical research-study design.
Swedish Clinical Research
601 Broadway Suite 600
Seattle, WA 98122
The American College of Rheumatology
The Arthritis Foundation
Return to Research Study Home Page
Rheumatology (not research):
Seattle Rheumatology Associates 206-386-2000